Patents matching “statin”

US 10407466

Methods of selecting compstatin mimetics

Apellis Pharmaceuticals, Inc. · Granted Sep 10, 2019 · Expires Sep 5, 2039

US 10351547

Somatostatin modulators and uses thereof

CRINETICS PHARMACEUTICALS, INC. · Granted Jul 16, 2019 · Expires Jul 11, 2039

US 10314892

Method of delivering a somatostatin compound into a lumen of the intestinal tract using a swallowable drug delivery device

Rani Therapeutics, LLC · Granted Jun 11, 2019 · Expires Jun 6, 2039

US 10308687

Cell-penetrating compstatin analogs and uses thereof

Apellis Pharmaceuticals, Inc. · Granted Jun 4, 2019 · Expires May 30, 2039

US 10266579

Synthetic somatostatin receptor ligands

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Apr 23, 2019 · Expires Apr 18, 2039

US 10226535

Auristatin compounds and conjugates thereof

Mersana Therapeutics, Inc. · Granted Mar 12, 2019 · Expires Mar 7, 2039

US 10125171

Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof

Apellis Pharmaceuticals, Inc. · Granted Nov 13, 2018 · Expires Nov 8, 2038

US 10035822

Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods

Apellis Pharmaceuticals, Inc. · Granted Jul 31, 2018 · Expires Jul 26, 2038

US 9970037

Methods and materials for making simvastatin and related compounds

The Regents of the University of California · Granted May 15, 2018 · Expires May 10, 2038

US 9919065

Somatostatin analogs with inhibitory activity to growth hormone release

The Regents of the University of California · Granted Mar 20, 2018 · Expires Mar 15, 2038

US 9902703

Somatostatin modulators and uses thereof

CRINETICS PHARMACEUTICALS, INC. · Granted Feb 27, 2018 · Expires Feb 22, 2038

US 9896432

Somatostatin modulators and uses thereof

CRINETICS PHARMACEUTICALS, INC. · Granted Feb 20, 2018 · Expires Feb 15, 2038

US 9820966

Stabilized statin formulations

Cumberland Pharmaceuticals Inc. · Granted Nov 21, 2017 · Expires Nov 16, 2037

US 9751878

Tetrahydronaphthyridine somatostatin receptor 5 antagonists

Takeda Pharmaceutical Company Limited · Granted Sep 5, 2017 · Expires Aug 31, 2037

US 9738721

Oncostatin M receptor antigen binding proteins

Kiniksa Pharmaceuticals, GmbH · Granted Aug 22, 2017 · Expires Aug 17, 2037

US 9731023

Somatostatin receptor-based cancer therapy

The Board of Regents of the University of Texas System · Granted Aug 15, 2017 · Expires Aug 10, 2037

US 9663571

Oncostatin M receptor antigen binding proteins

Kiniksa Pharmaceuticals, GmbH · Granted May 30, 2017 · Expires May 25, 2037

US 9593163

Oncostatin M receptor antigen binding proteins

Kiniksa Pharmaceuticals, GmbH · Granted Mar 14, 2017 · Expires Mar 9, 2037

US 9572862

Methods for promoting lipolysis and oxidation in liver and adipose tissue using catestatin

The Regents of the University of California · Granted Feb 21, 2017 · Expires Feb 16, 2037

US 9539342

Auristatin tyramine phosphate salts and auristatin aminoquinoline derivatives and prodrugs thereof

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jan 10, 2017 · Expires Jan 5, 2037

US 9517233

Local cochlear application of statins for stimulating neurite regrowth in the cochlea

Northwestern University · Granted Dec 13, 2016 · Expires Dec 8, 2036

US 9512180

Compstatin analogs

The Regents of the University of California · Granted Dec 6, 2016 · Expires Dec 1, 2036

US 9421240

Compstatin analogs for treatment of neuropathic pain

Apellis Pharmaceuticals, Inc. · Granted Aug 23, 2016 · Expires Aug 18, 2036

US 9353108

Tetrahydronaphthyridine somatostatin receptor 5 antagonists

Takeda Pharmaceutical Company Limited · Granted May 31, 2016 · Expires May 26, 2036